Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-13-005072
Filing Date
2013-03-13
Accepted
2013-03-13 17:46:16
Documents
2
Period of Report
2013-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2270
2 EXHIBIT 24 POWER OF ATTORNEY ex24ramachandra.txt EX-24 3713
  Complete submission text file 0001179110-13-005072.txt   7128
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 275 NORTH FIELD DRIVE LAKE FOREST IL 60045
Business Address
Ramachandra Sumant (Reporting) CIK: 0001439368 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 13688414